Midi Clinical Patient Site At Nih Cc is categorized under Commercial Biotechnical Research in Bethesda, MD and active since 2006.
Midi Clinical Patient Site At Nih Cc was established in 2006, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Han Xu at the company’s single location by writing to 10 Cloister Court, Bethesda, Maryland MD 20814 or by phoning (301) 222-7143. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Midi Clinical Patient Site At Nih Cc |
| Contact Person: | Han Xu |
| Address: | 10 Cloister Court, Bethesda, Maryland 20814 |
| Phone Number: | (301) 222-7143 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Midi Clinical Patient Site At Nih Cc was started in 2006 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Han Xu for inquiries that concern Midi Clinical Patient Site At Nih Cc by calling the company number (301) 222-7143, as your correspondence is most welcome. Additionally, the physical location of the single location of Midi Clinical Patient Site At Nih Cc can be found at the coordinates 39.029996,-77.097074 as well as the street address 10 Cloister Court in Bethesda, Maryland 20814.
For its online presence, you may visit Midi Clinical Patient Site At Nih Cc’s website at and engage with its social media outlets through on Twitter and on Facebook.